about
sameAs
Modular design of artificial tissue homeostasis: robust control through synthetic cellular heterogeneity'Glocal' robustness analysis and model discrimination for circadian oscillators.LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures.Efficient characterization of high-dimensional parameter spaces for systems biology.Effect of network architecture on synchronization and entrainment properties of the circadian oscillations in the suprachiasmatic nucleusAnalysis of growth factor signaling in genetically diverse breast cancer linesProfiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.Mapping behavioral specifications to model parameters in synthetic biology.Fractional killing arises from cell-to-cell variability in overcoming a caspase activity thresholdGrowth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.L1000CDS2: LINCS L1000 characteristic direction signatures search engineA Quantitative Approach to Screen for Nephrotoxic Compounds In VitroExplaining the length threshold of polyglutamine aggregation.Deterministic characterization of phase noise in biomolecular oscillators.Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics.Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.A multi-center study on factors influencing the reproducibility of in vitro drug-response studiesA multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
P50
Q28481407-DB6C610E-4D59-47C7-B143-8F2DCE9983B6Q33510924-FBD0467E-8020-4428-B765-24CA2C6AF72AQ33860855-D3563A47-26B5-491A-8FDA-31D13E8E0CC2Q34020133-B2ED8582-5EDF-4E98-AB63-B676DF5B2880Q34197828-7B7BD33B-CA86-40C2-89A1-7ABC22192491Q34522964-538CA3C9-5A02-40C4-8DCE-C0CAD1348673Q34996693-8B5F8382-2638-4212-AAEE-34A5A82BBD02Q35051300-D43A7641-C62B-4095-9854-03A845B187BCQ35705510-76B2EEA0-E187-4245-86AC-9F3A24830110Q36005156-F75CF376-9496-47B3-89E8-D0AF5D1572C9Q36348069-E95E5BC4-B7C8-4367-A9A0-65AE2C76AACCQ36746077-7AF659B2-ABBB-4960-8532-70496799B647Q38010908-AC18615B-A5C9-4B21-98D1-D3048C9C533DQ39289363-EAB289E2-C0ED-4411-9A7F-4D508441722EQ43635406-F37C74F8-AD90-42C7-AFEB-D3FDC4920707Q47111961-4DF1132D-E8B4-4D2B-91BA-6F828B01BDDAQ48312920-74FBCCCC-2C99-4918-B030-61B88AD1BD13Q59549656-0084D6A1-9B36-4556-80F8-F6BFCF2D8B49Q64911527-F952B07E-B3F0-45CB-88F4-33B8C6961338Q92615724-F09292D9-E601-451C-8645-2FEF0DC889A3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marc Hafner
@ast
Marc Hafner
@en
Marc Hafner
@es
Marc Hafner
@sl
type
label
Marc Hafner
@ast
Marc Hafner
@en
Marc Hafner
@es
Marc Hafner
@sl
prefLabel
Marc Hafner
@ast
Marc Hafner
@en
Marc Hafner
@es
Marc Hafner
@sl
P106
P1153
35271523600
P21
P2456
P2798
P31
P3835
marc-hafner
P496
0000-0003-1337-7598